Asia · Regional markets · Tech in Asia

OpenAI acquires biopharma software platform Orchestra Bio

Published by Tech in Asia · Singapore 4 h ago

Per OpenAI, drug development takes about 10 to 15 years on average from discovery to US approval.

Read the full article on Tech in Asia Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.techinasia.com)

Also worth reading

SCHOTT Poonawalla, backed by Germany’s SCHOTT Pharma and TPG Growth, begins work on $400 million India IPO

SpaceX Q3 2026 results: Shares jump 8% in pre-market after $4.4 billion profit; what Musk said on SpaceX-Tesla merger

Business Standard

Hero Motors, SML Mahindra, Wheels India locked at 10% lower circuits

The Straits Times Business

OCBC customers can hold Malaysian ringgit in Singapore savings accounts from Oct 23

The Business Times

Temasek and GIC deny instigating Indonesian stock rout

Pulse (Maeil Business)

Hiring at Korea’s top banks drops nearly 40% in three years